I don't agree Jason Napodono. Negative ALD-401 results will wither the stock price IMO, regardless of where the PPS is when the results are announced. I'm looking at plenty of compannies right now that are trading well below the PPS at which they sold shares. Especially now, with the bio sector reeling, any bad news is going to impact heavily to the downside.
I agree with you- trial results are going to have to be quite strong to show serious efficacy. If they hit, it'll definitely hike the stock price over a buck. Maybe it's enouraging that CMXI negotiated their recent financing to give them an opportunity to seek better terms if ALD hits, but it's all conjecture at this point.
That said, IMO, it's a big risk to hold CMXI through the results PR. And that said, I'm still not sure what I'll do with my shares, lol
